DASATINIB 70 mg in Mexico is prescribed for the management of chronic myeloid leukemia (blood cancer) in cases where other leukemia medications have proven ineffective or are not suitable due to adverse reactions.

DASATINIB 70 mg Tablet can be consumed with or without food, but it is recommended to maintain a consistent daily schedule to maximize its effectiveness. Your doctor will determine the appropriate dosage and frequency based on your specific condition, and these may be subject to adjustments over time. Adhering to your doctor’s instructions is crucial, as improper usage or excessive intake can result in severe side effects. While the positive effects may take weeks or months to become noticeable, it is important not to discontinue the medication unless directed by your doctor. 

USES OF DASATINIB 70 MG 

This medication is employed in the treatment of specific cancer types, namely chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Its mechanism involves impeding or halting the growth of cancer cells.

HOW TO USE DASATINIB TABLET:

Before commencing DASATINIB 70MG and with each refill, it is advisable to read the Patient Information Leaflet provided by your pharmacist. Should you have any inquiries, consult your doctor or pharmacist.

Follow your doctor’s instructions and take this medication orally, with or without food, typically once daily. Ingest the tablets whole and do not crush, chew, or break them.

Your dosage is determined by factors such as your medical condition, response to treatment, laboratory test results, and concurrent use of other medications. For children, the dosage is weight-dependent. Inform your doctor and pharmacist about all the products you are using, including prescription drugs, nonprescription drugs, and herbal products. 

Avoid escalating your dose or using this medication more frequently or for a prolonged duration beyond the prescribed guidelines. Doing so will not expedite the improvement of your condition, and it will elevate the risk of encountering severe side effects.

Refrain from using antacids (such as aluminum/magnesium hydroxide, calcium carbonate) within a 2-hour window before or after consuming this medication, as they can hinder the complete absorption of the drug by your body.

Refrain from consuming grapefruit or grapefruit juice while on this medication unless explicitly permitted by your doctor or pharmacist. The interaction with grapefruit can heighten the risk of side effects associated with this medicine. Consult your doctor or pharmacist for additional information.

Pregnant women or those planning to conceive should avoid handling this medication or inhaling dust from the tablets, as the drug can be absorbed through the skin and lungs, potentially posing a risk to the unborn baby.

SIDE EFFECTS OF DASATINIB 70 MG: 

You may experience diarrhea, nausea/vomiting, muscle/joint pain, or headache. If any of these effects persist or worsen, promptly inform your doctor or pharmacist.

Individuals utilizing this medication may encounter significant side effects. Nevertheless, your doctor has prescribed this drug based on the assessment that the advantages to your health outweigh the potential risks of side effects. Diligent monitoring by your doctor can reduce the likelihood of adverse effects.

If you experience any severe side effects, promptly inform your doctor. These may include a persistent dry cough, swelling or pain in the hands/ankles/feet, abrupt and unexplained weight gain, shortness of breath, or indications of liver disease, such as unrelenting nausea/vomiting, loss of appetite, stomach/abdominal pain, yellowing of the eyes/skin, or dark urine.

The rapid destruction of cancer cells by DASATINIB 70 MG  can occasionally lead to side effects known as tumor lysis syndrome. To mitigate this risk, your doctor may prescribe additional medication and advise you to increase fluid intake. Inform your doctor promptly if you experience symptoms like low back/side pain (flank pain), indications of kidney issues (such as painful urination, pink/bloody urine, alterations in urine volume), or muscle spasms/weakness.

This medication diminishes bone marrow function, potentially resulting in reduced levels of blood cells, including red cells, white cells, and platelets. This impact can lead to conditions like anemia, weakened ability to combat infections, or susceptibility to easy bruising/bleeding. Promptly inform your doctor if you experience any of the following symptoms: unusual fatigue, pale skin, signs of persistent infection (such as a lingering sore throat, fever, chills), or easy bruising/bleeding.

PRECAUTIONS OF DASATINIB 70 MG 

Prior to initiating DASATINIB 70 MG , inform your doctor or pharmacist about any allergies you may have, whether to DASATINIB itself or to other substances. This product may contain inactive ingredients, such as lactose, that can potentially trigger allergic reactions or other complications. Consult with your pharmacist for further information.

Prior to initiating this medication, disclose your medical history to your doctor or pharmacist, particularly if you have a history of bleeding problems, current or recent infections, heart issues (such as irregular heartbeat), or liver problems (such as hepatitis B).

DASATINIB 70 MG  has the potential to induce a condition impacting the heart rhythm known as QT prolongation. In rare instances, QT prolongation may lead to a serious (and rarely fatal) acceleration or irregularity of the heartbeat, accompanied by symptoms such as severe dizziness and fainting. Immediate medical attention is necessary if these symptoms occur.

DASATINIB 70 MG  can increase your susceptibility to infections or worsen existing infections. Avoid close contact with individuals who have contagious infections, such as chickenpox, COVID-19, measles, or the flu. If you have been exposed to an infection or need more information, consult your doctor.

Inform your healthcare provider about your use of DASATINIB 70 MG before undergoing any immunizations or vaccinations. Steer clear of individuals who have recently received live vaccines, such as the flu vaccine administered through nasal inhalation.

This medication could impact the bone growth and development of a child. Seek advice from the doctor or pharmacist for additional details.

Pregnant women or those planning to conceive should refrain from handling this medication or inhaling dust from the tablets, as the drug can be absorbed through the skin and lungs, potentially causing harm to an unborn baby.

Inform your doctor of your pregnancy status or plans for conception. It is crucial to avoid pregnancy while using DASATINIB 70 MG, as it may pose harm to an unborn baby. Your doctor will likely recommend a pregnancy test before initiating this medication. Both men and women using this drug should inquire about dependable forms of birth control throughout the treatment period and for 30 days following the last dose. If pregnancy occurs, promptly discuss with your doctor the potential risks and benefits associated with continuing this medication.

The passage of this drug into breast milk is uncertain. Due to the potential risk to the infant, it is advised to refrain from breastfeeding while using this medication and for 2 weeks following the last dose. Seek guidance from your doctor before considering breastfeeding.

INTERACTIONS:

Interactions between drugs can alter the effectiveness of your medications or elevate the risk of serious side effects. This information may not encompass all potential drug interactions. Maintain a comprehensive list of all products you use, including prescription/nonprescription drugs and herbal products, and disclose it to your doctor and pharmacist. Avoid initiating, discontinuing, or adjusting the dosage of any medicines without obtaining approval from your doctor.

Certain products that might interact with this medication include: other drugs known to cause bleeding or bruising (including antiplatelet drugs like clopidogrel, NSAIDs such as ibuprofen or naproxen, and anticoagulants such as warfarin or dabigatran), as well as medications that decrease stomach acid (e.g., antacids, H2 blockers like famotidine or ranitidine, proton pump inhibitors like omeprazole).

Various medications can influence the elimination of DASATINIB from your system, potentially impacting its efficacy. Examples of such medications include azole antifungals (like itraconazole and ketoconazole), dexamethasone, macrolide antibiotics (such as clarithromycin), RIFAMYCINS (like rifampin and rifabutin), saquinavir, St. John’s wort, telithromycin, and others.